SEC Form 4 · accession 0001645627-17-000141
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Nov 20, 2017
Accepted (ET)
Nov 21, 2017 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 20, 2017 | P | 3,000 | $0.0449 | A | 24,237,189 | D | |
| Common Stock | Nov 20, 2017 | P | 3,000 | $0.05 | A | 24,240,189 | D | |
| Common Stock | Nov 20, 2017 | P | 3,000 | $0.051 | A | 24,243,189 | D | |
| Common Stock | Nov 20, 2017 | P | 3,000 | $0.055 | A | 24,246,189 | D | |
| Common Stock | Nov 20, 2017 | P | 3,000 | $0.057 | A | 24,249,189 | D | |
| Common Stock | Nov 20, 2017 | P | 3,000 | $0.057 | A | 24,252,189 | D |
Table II — derivative securities
No Table II lines on this filing.